Jeanne Cunicelli has been named president of UPMC Enterprises succeeding Tal Heppenstall, who is retiring from UPMC after 17 years.
Cunicelli, who has led Enterprises’ Translational Sciences focus area since 2017, will take over on Jan. 1, 2021. She is a veteran venture capitalist in the life sciences industry, having been a managing director at Bay City Capital in San Francisco before joining UPMC.
Under Cunicelli’s leadership, the Translational Sciences team has grown to more than 20 scientific and investment professionals working to accelerate the transfer of scientific discoveries into life-changing medicines, diagnostics, and devices.
The team has formed five startup companies based on University of Pittsburgh research and is expanding its focus nationally and internationally to deploy $1 billion by 2024 in life sciences to grow their portfolio of syndicated investments alongside their company formation efforts. Collaborating with other leading venture capital firms, the team has participated in investment rounds for Werewolf Therapeutics and Cerevance.
Cunicelli, who will also become an executive vice president at UPMC, earned an MBA in finance from the University of San Francisco and a bachelor’s degree from Carnegie Mellon University, where she is currently a member of the board of trustees.
How to Build A Race Car… Or A Really Good Agile Program
Building a great agile program is hard and an ever-evolving activity. It’s complex and requires system-level thinking with an intuitive understanding of engineering tradeoffs, bottlenecks, and flow dynamics. Much like a racecar driver, one cannot expect a driver to understand and be consciously aware of every detail happening in his car while he is racing down the track.
The Football Framework: Learning from the Gridiron
— WRITTEN AS A SPEECH OUTLINE —
Do you know what the greatest professional football dynasties …
Everything Is Made Up… and The Points Don’t Matter
Think about what’s important. Measure that. Adjust. Repeat.